Finance

Beta
Lists
GLMD:NASDAQ
Galmed Pharmaceuticals Ltd
$0.70
-4.67%
(-0.034) 1D
$0.70
+0.17% (+0.0012)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLMD...
Open
$0.73
High
$0.73
Low
$0.69
Mkt. cap
4.59M
Avg. vol.
130.96K
Volume
121.70K
52-wk high
$2.34
52-wk low
$0.41
EPS
-$2.39
Beta
0.73
Shares outstanding
6.60M
No. of employees
5
Open
$0.73
High
$0.73
Low
$0.69
Mkt. cap
4.59M
Avg. vol.
130.96K
Volume
121.70K
52-wk high
$2.34
52-wk low
$0.41
EPS
-$2.39
Beta
0.73
Shares outstanding
6.60M
No. of employees
5
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to GLMD in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for GLMD in the last 3 months.
Highest
Current $0.70
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
News stories
From sources across the web
About Galmed Pharmaceuticals Ltd
CEO-
Employees5
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
634.00K
1.06M
1.09M
2.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
630.00K
1.05M
1.01M
946.00K
Operating expense
1.26M
2.11M
2.10M
3.04M
Total operating expenses
1.26M
2.11M
2.10M
3.04M
Operating income
-1.26M
-2.11M
-2.10M
-3.04M
Other non operating income
160.00K
-
-
-16.00K
EBT including unusual items
-1.10M
-2.50M
-1.89M
-4.82M
EBT excluding unusual items
-1.10M
-1.97M
-1.89M
-2.79M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.10M
-2.50M
-1.89M
-4.82M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
140.00K
203.00K
420.00K
Interest expense
-
-
-
-79.00K
Net interest expenses
-
140.00K
203.00K
341.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.24M
-2.09M
-2.07M
-3.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more